SillaJen's Private Equity Round

SillaJen raised a round of funding on March 21, 2016. Investors include Medivate Partners.

SillaJen is a clinical-stage biotherapeutics company that focuses on the development and commercialization of oncolytic immunotherapy products for cancer. The Company develops Pexa-Vec, an oncolytic i…

Articles about SillaJen's Private Equity Round: